Expectant mothers may use RA drugs without increased health risks to unborn babies

News-Medical.Net Pharmaceutical News - Thu, 2018-05-17 01:18
A new study led by a team at the Research Institute of the MUHC in Montreal has revealed that pregnant women with rheumatoid arthritis may be able to use certain RA drugs without possible increased health risks to their unborn babies.
Categories: News

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

News-Medical.Net Pharmaceutical News - Wed, 2018-05-16 21:42
The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.
Categories: News

Mayo Clinic researchers identify new possible treatment choice for triple negative breast cancer

News-Medical.Net Pharmaceutical News - Wed, 2018-05-16 19:42
In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is one of the most aggressive and lethal types of breast cancer.
Categories: News
Syndicate content